Sign in

CIK 0001093557

  • Large accelerated filer
Ticker
DXCM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330857544
Phone
+1 858-200-0200
Business address
6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,328,435
in 8 filings, $4.3M under 10b5-1 plans

Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-29 Dolan Matthew Vincent EVP, Strategy & Corporate Dev Sale −1,183 $86.91 $103K 42,044
2025-01-28 Dolan Matthew Vincent EVP, Strategy & Corporate Dev Grant or award +3,048 43,227
2024-05-15 Dolan Matthew Vincent EVP Strategy and Corporate Dev Sale 10b5-1 −2,423 $126.58 $307K 40,075
2024-04-15 Dolan Matthew Vincent EVP Strategy and Corporate Dev Sale 10b5-1 −1,990 $137.81 $274K 42,377
2024-03-15 Dolan Matthew Vincent EVP Strategy & Corp Dev Sale 10b5-1 −1,886 $129.18 $244K 46,684
2024-03-15 Dolan Matthew Vincent EVP Strategy & Corp Dev Sale 10b5-1 −1,314 $130.77 $172K 45,370
2024-03-15 Dolan Matthew Vincent EVP Strategy & Corp Dev Sale 10b5-1 −1,003 $131.39 $132K 44,367
2024-03-12 Dolan Matthew Vincent EVP Strategy and Corporate Sale −6,710 $134.41 $902K 48,570
2024-03-08 Dolan Matthew Vincent EVP Strategy and Corporate Grant or award +21,711 55,280
2023-09-01 Dolan Matthew Vincent SVP Corporate Strategy-Develop Sale −56 $102.32 $6K 33,569
2023-03-16 Dolan Matthew Vincent SVP Corporate Strategy-Develop Sale −2,303 $115.00 $265K 33,569
2023-03-13 Dolan Matthew Vincent SVP Corporate Strategy-Develop Sale −6,229 $106.27 $662K 35,872
2023-03-10 Dolan Matthew Vincent SVP Corporate Strategy-Develop Returned to the company −1,370 $111.40 $153K 46,935
2023-03-10 Dolan Matthew Vincent SVP Corporate Strategy-Develop Returned to the company −1,650 $111.40 $184K 45,285
2023-03-10 Dolan Matthew Vincent SVP Corporate Strategy-Develop Returned to the company −2,397 $111.40 $267K 42,888
2023-03-10 Dolan Matthew Vincent SVP Corporate Strategy-Develop Returned to the company −787 $111.40 $88K 42,101
2023-03-08 Dolan Matthew Vincent SVP Corporate Strategy-Develop Grant or award +21,769 $0.00 $22 48,305
2023-03-06 Dolan Matthew Vincent SVP Corporate Strategy-Develop Sale −226 $114.40 $26K 26,536
2022-09-01 Dolan Matthew Vincent SVP Corporate Strategy-Develop Sale −5 $81.63 $408 26,536
2022-03-17 Dolan Matthew Vincent SVP Corporate Development Sale −484 $450.00 $218K 6,634

Page 1 of 2 · 27 trades